As of 2025-10-19, the Relative Valuation of Gossamer Bio Inc (GOSS) is (4.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.19 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -288.1%.
The range of the Relative Valuation is (1.65) - (6.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 11.0x | 6.8x |
| Forward P/E multiples | 2.7x - 10.9x | 6.8x |
| Fair Price | (1.65) - (6.57) | (4.12) |
| Upside | -175.5% - -399.8% | -288.1% |
| Date | P/E |
| 2025-10-17 | -3.63 |
| 2025-10-16 | -3.83 |
| 2025-10-15 | -3.99 |
| 2025-10-14 | -3.94 |
| 2025-10-13 | -4.04 |
| 2025-10-10 | -3.78 |
| 2025-10-09 | -4.24 |
| 2025-10-08 | -4.01 |
| 2025-10-07 | -4.14 |
| 2025-10-06 | -3.99 |
| 2025-10-03 | -4.26 |
| 2025-10-02 | -4.11 |
| 2025-10-01 | -4.13 |
| 2025-09-30 | -4.36 |
| 2025-09-29 | -4.67 |
| 2025-09-26 | -4.47 |
| 2025-09-25 | -4.61 |
| 2025-09-24 | -4.95 |
| 2025-09-23 | -5.10 |
| 2025-09-22 | -5.24 |
| 2025-09-19 | -5.05 |
| 2025-09-18 | -5.10 |
| 2025-09-17 | -4.95 |
| 2025-09-16 | -5.30 |
| 2025-09-15 | -5.27 |
| 2025-09-12 | -5.73 |
| 2025-09-11 | -5.73 |
| 2025-09-10 | -5.15 |
| 2025-09-09 | -4.59 |
| 2025-09-08 | -4.41 |
| 2025-09-05 | -4.87 |
| 2025-09-04 | -4.16 |
| 2025-09-03 | -4.27 |
| 2025-09-02 | -4.29 |
| 2025-08-29 | -4.09 |
| 2025-08-28 | -3.98 |
| 2025-08-27 | -4.08 |
| 2025-08-26 | -4.19 |
| 2025-08-25 | -3.91 |
| 2025-08-22 | -3.88 |
| 2025-08-21 | -3.60 |
| 2025-08-20 | -3.23 |
| 2025-08-19 | -3.18 |
| 2025-08-18 | -3.30 |
| 2025-08-15 | -3.25 |
| 2025-08-14 | -3.25 |
| 2025-08-13 | -3.26 |
| 2025-08-12 | -3.20 |
| 2025-08-11 | -2.87 |
| 2025-08-08 | -2.92 |